Skip to main content

“There are a terrible lot of lies going about the world, and the worst of it is that half of them are true.” – Win

Social Author Name
Dr. John Cush
Tweet Content
“There are a terrible lot of lies going about the world, and the worst of it is that half of them are true.” – Winston Churchill

HCQ Preserves Renal Function in Lupus Nephritis Lupus nephritis (LN) patients on long-term therapy with hydroxychloroq

Social Author Name
Dr. John Cush
Tweet Content
HCQ Preserves Renal Function in Lupus Nephritis Lupus nephritis (LN) patients on long-term therapy with hydroxychloroquine (HCQ) showed significantly less decline in renal function, compared with patients treated otherwise, a 10-year retrospective study indicated. https://t.co/YpJGpAysUQ

Top 20 Best Rheumatology Hospitals - 2025 Each year, U.S. News ranks hospitals in 15 specialties and for the 8th year

Social Author Name
Dr. John Cush
Tweet Content
Top 20 Best Rheumatology Hospitals - 2025 Each year, U.S. News ranks hospitals in 15 specialties and for the 8th year in a row Johns Hopkins Hospital in Baltimore has been named the top hospital for rheumatology by U.S. News & World Report. https://t.co/gBA49giwX7 https://t.co/sObhLxgrBf

MTX or TNFi use in elderly #RA pts w/in a year of Dx of melanoma was not associated with increased mortality. This inclu

Social Author Name
Dr. John Cush
Tweet Content
MTX or TNFi use in elderly #RA pts w/in a year of Dx of melanoma was not associated with increased mortality. This included melanoma in situ (48%), localized (47%) and regional (5%) melanoma. Steroid use however was assoc w/ reduced survival. https://t.co/QOXfEf51S1 https://t.co/GZ5dedEMfM
A New RA Approval (8.1.2025)

Dr. Jack Cush reviews the news, journal reports and a new treatment for RA from the FDA.

Rituximab is not Superior in EGPA A cohort study of Eosinophilic Granulomatosis With Polyangiitis (EGPA) patients from

Social Author Name
Dr. John Cush
Tweet Content
Rituximab is not Superior in EGPA A cohort study of Eosinophilic Granulomatosis With Polyangiitis (EGPA) patients from the French Vasculitis Study Group failed to show superiority of rituximab compared to conventional strategy with glucocorticoids (GS) alone or in combination https://t.co/h4B20Ngamj
Navigating the Path to SLE Remission
Watch rheumatologists Dr Anca Askanase and Dr Cristina Arriens discuss their clinical perspectives on how to target and achieve DORIS remission in clinical practice.

FDA is evaluating the safety of Vyvgart Hytrulo, ((efgartigimod) used to treat AChR Ab positive generalized myasthenia

Social Author Name
Dr. John Cush
Tweet Content
FDA is evaluating the safety of Vyvgart Hytrulo, ((efgartigimod) used to treat AChR Ab positive generalized myasthenia gravis (gMG). But in clinical trials there are reports of "severe worsening of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)” https://t.co/KN7ZZ2LWPW

PMR & GCA not assoc w/ increased mortality, Norway study of 274 isolated PMR (mean age 72 yrs) & 63 GCA (age 72

Social Author Name
Dr. John Cush
Tweet Content
PMR & GCA not assoc w/ increased mortality, Norway study of 274 isolated PMR (mean age 72 yrs) & 63 GCA (age 72 yrs) pts. After mean F/U 13.7 yrs 96% were deceased. Standardized mortality ratio was Not incr for PMR (0.97)or GCA (1.10), but men w/ PMR had , lower all-cause https://t.co/wbiVhjCimk
Subscribe to
×